HSE urged to continue talks over Skyclarys treatment for Friedreich's ataxia patients

Rare Disease Ireland group 'has never publicly called for the reimbursement of a single medicine', with appeal made ahead of decision on Tuesday as to whether Skyclarys will be funded for patients